Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic mycophenolate mofetil 250 mg vs CELLCEPT 250 mg under fasting in healthy Thai male volunteers
TCTR20260601008Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mycophenolate mofetil (2 arms), sponsored by International Bio Service. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
Beyond the preview
Go deeper on TCTR20260601008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260601008.